Apolipoprotein E epsilon 4 allele (APOE epsilon 4) and Alzheimer's disease: role of genetic testing for diagnosis and risk assessment.
D000544:Alzheimer Disease / Q000175:diagnosis / Q000235:genetics*; D001057:Apolipoproteins E; D054598:Blue Cross Blue Shield Insurance Plans; D018795:Device Approval; D005820:Genetic Testing / Q000379:methods; D006801:Humans; D017063:Outcome Assessment, Health Care; D011237:Predictive Value of Tests; D011446:Prospective Studies; D018570:Risk Assessment; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration
D001057:Apolipoproteins E